Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | ARGX | ARGENX SE | Healthcare | 19,955.0 | $18.5M | 0.64% | +16K | +470.1% | $927.77 | +12.9% |
| 42 | NVCT | NUVECTIS PHARMA INC | Healthcare | 1,000,000.0 | $18.4M | 0.63% | NEW | — | $18.39 | +35.9% |
| 43 | CAPR | CAPRICOR THERAPEUTICS INC | Healthcare | 761,737.0 | $18.3M | 0.63% | NEW | — | $24.08 | -61.1% |
| 44 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 450,889.0 | $18.3M | 0.63% | -999K | -68.9% | $40.63 | +9.2% |
| 45 | PRLD | PRELUDE THERAPEUTICS INC | Healthcare | 3,378,378.0 | $18.0M | 0.62% | NEW | — | $5.33 | +23.1% |
| 46 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 267,000.0 | $16.1M | 0.56% | -25K | -8.6% | $60.36 | +5.7% |
| 47 | CCCC | C4 THERAPEUTICS INC | Healthcare | 3,377,981.0 | $15.8M | 0.54% | -426K | -11.2% | $4.67 | -9.2% |
| 48 | — | KINIKSA PHARMACEUTICALS INTL | — | 246,353.0 | $15.8M | 0.54% | -275K | -52.8% | $63.95 | — |
| 49 | KIDS | ORTHOPEDIATRICS CORP | Healthcare | 732,144.0 | $14.0M | 0.48% | +117K | +19.0% | $19.13 | +25.6% |
| 50 | — | AVALYN PHARMACEUTICALS INC | — | 419,000.0 | $13.8M | 0.47% | NEW | — | $32.92 | — |
| 51 | BDSX | BIODESIX INC | Healthcare | 585,958.0 | $13.2M | 0.46% | +169K | +40.6% | $22.55 | +35.7% |
| 52 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 147,000.0 | $13.1M | 0.45% | NEW | — | $88.78 | +5.4% |
| 53 | TWST | TWIST BIOSCIENCE CORP | Healthcare | 104,629.0 | $10.8M | 0.37% | -1.1M | -91.5% | $102.88 | +45.9% |
| 54 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 1,000,000.0 | $10.2M | 0.35% | -1.0M | -50.0% | $10.19 | +8.7% |
| 55 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 33,050.0 | $9.9M | 0.34% | -99K | -74.9% | $301.03 | -20.6% |
| 56 | IMVT | IMMUNOVANT INC | Healthcare | 252,000.0 | $9.7M | 0.34% | +22K | +9.6% | $38.53 | +13.9% |
| 57 | INSM | INSMED INC | Healthcare | 90,250.0 | $9.6M | 0.33% | +80K | +780.5% | $106.62 | +16.7% |
| 58 | SEPN | SEPTERNA INC | Healthcare | 275,000.0 | $9.2M | 0.32% | — | — | $33.49 | +20.2% |
| 59 | SOPH | SOPHIA GENETICS SA | Healthcare | 1,565,000.0 | $9.0M | 0.31% | -285K | -15.4% | $5.77 | +47.8% |
| 60 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 128,362.0 | $9.0M | 0.31% | NEW | — | $69.81 | +5.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%